Latest market news

Nanexa shares surge 150% after $1bn Novo Nordisk licensing deal

Nanexa shares rose more than 150% in a single session after the Stockholm-listed microcap announced a licensing agreement with Novo Nordisk valued at over $1 billion, covering injectable formulations and delivery systems.

MDT Q3 2026: filings, holdings, and macro context

CVS Q3 2026: filings, holdings, and macro context

GILD Q3 2026 update — filings and holdings

TMO Q3 2026 update — filings and holdings

ABT Q3 2026 update — filings and holdings

JNJ Q3 2026 update — filings and holdings

ABBV Q3 2026: filings, holdings, and macro context

AMGN Q3 2026 update — filings and holdings

PFE Q3 2026 update — filings and holdings

MRK Q3 2026 update — filings and holdings

LLY Q3 2026 update — filings and holdings

UNH Q2 2026: filings, holdings, and macro context

MDT Q3 2026: filings, holdings, and macro context

CVS Q3 2026 update — filings and holdings

GILD Q3 2026 update — filings and holdings

ABT Q3 2026 update — filings and holdings

JNJ Q2 2026: filings, holdings, and macro context

ABBV Q3 2026 update — filings and holdings

AMGN Q2 2026: filings, holdings, and macro context